University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Dana P. McGlothlin

Dana P. McGlothlin, M.D.

Cardiologist

Dr. Dana McGlothlin is a cardiologist specializing in echocardiography. She has a particular interest in pulmonary hypertension and adult congenital heart disease. In addition, her research interests include cardiovascular issues in pregnancy.

McGlothlin earned her medical degree from the University of Kansas School of Medicine in Kansas City, Kan. She went on to complete her residency in internal medicine at the Mayo Clinic in Scottsdale, Ariz., where she also completed a cardiovascular fellowship. McGlothlin then came to the University of California, San Francisco for an echocardiography fellowship.

Conditions & Treatments

Clinics

Advanced Heart Failure Evaluation and Therapies Program
400 Parnassus Ave., Sixth Floor, Suite A-6110
San Francisco, CA 94143-0118
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday
8 a.m. – 3 p.m.

Cardiovascular Genetics Program
400 Parnassus Avenue, Plaza Level, Room 94
San Francisco, CA 94143
Phone: (415) 476-5354
Fax: (415) 476-5355

Hours: Monday
noon – 4 p.m

Heart Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on the number of doctors in clinic)

Pulmonary Hypertension Clinic
400 Parnassus Ave., Plaza Level
San Francisco, CA 94143
Phone: (415) 353-9088
Fax: (415) 353-3889

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

More about Dana P. McGlothlin

Education

University of Kansas, School of Medicine 1996

Residencies

Mayo Clinic Scottsdale, Internal Medicine 1999

Fellowships

Mayo Clinic Scottsdale, Cardiology 2002
UCSF Medical Center, Echocardiography 2003

Selected Research and Publications

  1. Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard EG, Rame JE. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A. 2011 Sep; 155A(9):2229-35.
  2. McGlothlin D, De Marco T. Transplantation in adults with congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb; 53(4):312-23.
  3. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant. 2009 Oct; 28(10):1081-6.
  4. Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009 Jun; 157(6):1026-34.
  5. Chatterjee K, McGlothlin D, Michaels A. Analytic reviews: cardiogenic shock with preserved systolic function: a reminder. J Intensive Care Med. 2008 Nov-Dec; 23(6):355-66.
  6. Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P, Jones RT. The clinical pharmacology of intranasal l-methamphetamine. BMC Clin Pharmacol. 2008; 8:4.
  7. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 2008 Jun 1; 177(11):1268-75.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California